Biotech



Bridging Finance Inc.
Latest Comments
image_pdfimage_print
 

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal


January 09, 2017
| January 09, 2017

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX |OTCQX: IGXT), discusses […]


 

IntelGenx CEO speaks to the potential impact of Montelukast on Alzheimers


January 03, 2017
| January 03, 2017

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX | OTCQX: IGXT) […]


IntelGenx takes migraine medication “head-on”


December 22, 2016
| December 22, 2016 | 1 Comment

The term a “bitter pill to swallow” may have been used as a figure of speech since the 17th century, […]


BlueOcean to tap “three huge markets” with the benefits of cannabis and sea


December 14, 2016
| December 14, 2016 | 1 Comment

BlueOcean NutraSciences Inc. (TSXV: BOC) has developed a science-based approach to leverage its current access to 63 retail stores and […]


 

André Godin on the IntelGenx license for Tadalafil erectile dysfunction dosing patent


December 06, 2016
| December 06, 2016

Andre Godin, Executive Vice President and CFO of IntelGenx Technologies Corp. (TSXV: IGX | OTCQX: IGXT), in an interview with […]


IntelGenX changing delivery of famous erectile dysfunction drug


November 22, 2016
| November 22, 2016 | 4 Comments

IntelGenX Technologies Corp. (TSXV: IGX | OTCQX: IGXT) announced the signing of a binding term sheet for a license to […]


BlueOcean Nutraceuticals Inc.